Cyclooxygenase-2 (Cox-2) in injured human nerve and a rat model of nerve injury.

Inflammation associated with nerve injury produces a number of pathogenic chemical mediators of which prostanoids are a potent component. Cyclooxygenases (Cox-1 and Cox-2) are the enzymes responsible for prostanoid production. We have investigated Cox-2 immunoreactivity (Cox-2-IR) and glial activati...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Durrenberger, P, Facer, P, Gray, R, Chessell, I, Naylor, A, Bountra, C, Banati, R, Birch, R, Anand, P
Fformat: Journal article
Iaith:English
Cyhoeddwyd: 2004
_version_ 1826304636603072512
author Durrenberger, P
Facer, P
Gray, R
Chessell, I
Naylor, A
Bountra, C
Banati, R
Birch, R
Anand, P
author_facet Durrenberger, P
Facer, P
Gray, R
Chessell, I
Naylor, A
Bountra, C
Banati, R
Birch, R
Anand, P
author_sort Durrenberger, P
collection OXFORD
description Inflammation associated with nerve injury produces a number of pathogenic chemical mediators of which prostanoids are a potent component. Cyclooxygenases (Cox-1 and Cox-2) are the enzymes responsible for prostanoid production. We have investigated Cox-2 immunoreactivity (Cox-2-IR) and glial activation in human injured (n = 16) and uninjured (n = 8) nerves and in the chronic constriction injury (CCI) model of nerve injury in the rat, using immunohistological and autoradiographic methods. Tissues were immunostained with antibodies to Cox-2, CD-68 (human macrophage marker), OX42 (rat microglial marker), or incubated with tritiated PK11195 (marker of glial activation), prior to image analysis. In human nerves, Cox-2-IR was detected in cells with morphology and distribution similar to macrophages/microglia - these were increased significantly in human nerve proximal to injury (p < 0.002), reaching a peak at 4-6 weeks after injury. In the rat CCI model, at 40 days after injury, microglia-like cells with Cox-2-IR were increased significantly in the injured nerve (p < 0.004) and ipsilateral dorsal spinal cord (p < 0.008). PK11195-binding results were similar for Cox-2-IR in chronic injured human nerve and rat tissues. These findings suggest that Cox-2-immunoreactive cells could play a role in processes associated with Wallerian degeneration, nerve regeneration, and the development of persistent pain. Selection of patients 4-6 weeks after nerve injury would be more likely to show any efficacy of Cox-2 inhibitors.
first_indexed 2024-03-07T06:20:49Z
format Journal article
id oxford-uuid:f2a6b10e-b529-455b-9a30-61e7146c7ca2
institution University of Oxford
language English
last_indexed 2024-03-07T06:20:49Z
publishDate 2004
record_format dspace
spelling oxford-uuid:f2a6b10e-b529-455b-9a30-61e7146c7ca22022-03-27T12:05:35ZCyclooxygenase-2 (Cox-2) in injured human nerve and a rat model of nerve injury.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:f2a6b10e-b529-455b-9a30-61e7146c7ca2EnglishSymplectic Elements at Oxford2004Durrenberger, PFacer, PGray, RChessell, INaylor, ABountra, CBanati, RBirch, RAnand, PInflammation associated with nerve injury produces a number of pathogenic chemical mediators of which prostanoids are a potent component. Cyclooxygenases (Cox-1 and Cox-2) are the enzymes responsible for prostanoid production. We have investigated Cox-2 immunoreactivity (Cox-2-IR) and glial activation in human injured (n = 16) and uninjured (n = 8) nerves and in the chronic constriction injury (CCI) model of nerve injury in the rat, using immunohistological and autoradiographic methods. Tissues were immunostained with antibodies to Cox-2, CD-68 (human macrophage marker), OX42 (rat microglial marker), or incubated with tritiated PK11195 (marker of glial activation), prior to image analysis. In human nerves, Cox-2-IR was detected in cells with morphology and distribution similar to macrophages/microglia - these were increased significantly in human nerve proximal to injury (p < 0.002), reaching a peak at 4-6 weeks after injury. In the rat CCI model, at 40 days after injury, microglia-like cells with Cox-2-IR were increased significantly in the injured nerve (p < 0.004) and ipsilateral dorsal spinal cord (p < 0.008). PK11195-binding results were similar for Cox-2-IR in chronic injured human nerve and rat tissues. These findings suggest that Cox-2-immunoreactive cells could play a role in processes associated with Wallerian degeneration, nerve regeneration, and the development of persistent pain. Selection of patients 4-6 weeks after nerve injury would be more likely to show any efficacy of Cox-2 inhibitors.
spellingShingle Durrenberger, P
Facer, P
Gray, R
Chessell, I
Naylor, A
Bountra, C
Banati, R
Birch, R
Anand, P
Cyclooxygenase-2 (Cox-2) in injured human nerve and a rat model of nerve injury.
title Cyclooxygenase-2 (Cox-2) in injured human nerve and a rat model of nerve injury.
title_full Cyclooxygenase-2 (Cox-2) in injured human nerve and a rat model of nerve injury.
title_fullStr Cyclooxygenase-2 (Cox-2) in injured human nerve and a rat model of nerve injury.
title_full_unstemmed Cyclooxygenase-2 (Cox-2) in injured human nerve and a rat model of nerve injury.
title_short Cyclooxygenase-2 (Cox-2) in injured human nerve and a rat model of nerve injury.
title_sort cyclooxygenase 2 cox 2 in injured human nerve and a rat model of nerve injury
work_keys_str_mv AT durrenbergerp cyclooxygenase2cox2ininjuredhumannerveandaratmodelofnerveinjury
AT facerp cyclooxygenase2cox2ininjuredhumannerveandaratmodelofnerveinjury
AT grayr cyclooxygenase2cox2ininjuredhumannerveandaratmodelofnerveinjury
AT chesselli cyclooxygenase2cox2ininjuredhumannerveandaratmodelofnerveinjury
AT naylora cyclooxygenase2cox2ininjuredhumannerveandaratmodelofnerveinjury
AT bountrac cyclooxygenase2cox2ininjuredhumannerveandaratmodelofnerveinjury
AT banatir cyclooxygenase2cox2ininjuredhumannerveandaratmodelofnerveinjury
AT birchr cyclooxygenase2cox2ininjuredhumannerveandaratmodelofnerveinjury
AT anandp cyclooxygenase2cox2ininjuredhumannerveandaratmodelofnerveinjury